Endocrine, Reproductive, and Cardiovascular Drugs
Complete the following and submit your answers.
Chapter 23, page 470, Case Study B- Antidiabetic Agents and page 471, questions 1 through 10.
Chapter 25, page 494, questions 1 through 10.
Case Study B - Antidiabetic Drugs
1. The physician starts him on glyburide, a sulfonylurea medication. He explains to Marcus that sulfonylureas work by:
2. The physician explains to Marcus that one of the side effects of a sulfonylurea medication is:
3. Prior to prescribing the medication, the physician reviews Marcus's medical history. This is because sulfonylureas must be used with extreme caution in individual's who:
4. The physician cautions Marcus to call him prior to taking any other medication because of possible interactions. Which drug can potentiate the hypoglycemic effect of a sulfonylurea?
5. What drug causes an interaction with sulfonylureas, resulting in antagonistic action in which a larger dose may be required?
Antidiabetic Agents and page 471, questions 1 through 10.
1. Glucophage - Oral antidiabetic agent
2. prednisone - Corticosteroid
3. Humulin R - Insulin: short acting
4. Synthroid - Thyroid agent
5. Avandia - Oral antidiabetic agent
6. Tapazole - Antithyroid
7. Isophane - Insulin: intermediate acting
8. Prandin - Oral antidiabetic agent
9. Lantus - Insulin: long acting
10. Humalog - Insulin: rapid acting
Chapter 25, page 494 (actually pg. 541), questions 1 through 10
1. isosorbide - Angina
2. Zetia - Elevated cholesterol
3. Lovenox - Pulmonary emboli
4. Cardizem - Hypertension
5. Zocor - Elevated cholesterol
6. Plavix - Stroke prevention (platelet inhibitor)
7. Crestor - Elevated cholesterol
8. hydralazine - Hypertension
9. quinidine - Cardiac arrhythmia
10. procainamide - Cardiac arrhythmia